FDA Nominee Addresses Vaccine Safety During Senate Hearing

Why it matters locally: The FDA's policies on vaccine safety and approval directly impact public health initiatives and vaccination schedules across Utah, including those for childhood immunizations managed by local health departments and medical providers statewide.

---

WASHINGTON – Heidi Overton, President Donald Trump's nominee to lead the Food and Drug Administration (FDA), spoke to senators Thursday during her confirmation hearing. Overton addressed the safety of long-established vaccines. Senators questioned Overton on the White House's initiatives regarding childhood immunizations. Her testimony followed President Trump's nomination for the FDA's top role.